https://www.selleckchem.com/pr....oducts/17-AAG(Geldan
increased the paclitaxel level in tumor tissues. Furthermore, compared with those of the other paclitaxel formulations, the cellular reactive oxygen species (ROS) and malondialdehyde (MDA) levels of the PTX/TQR NPs@NanoRBC-PEG/FA group increased by 1.38-fold (p less then 0.01) and 1.36-fold (p less then 0.01), respectively, and the activities of superoxide dismutase (SOD) and catalase (CAT) decreased to 67.8% (p less then 0.01) and 65.4% (p less then 0.001), respectively. More importantly, in vivo antitumor efficacy results
Like
Comment
Share
